| Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease M Fuhrmann, T Bittner, CKE Jung, S Burgold, RM Page, G Mitteregger, ... Nature neuroscience 13 (4), 411-413, 2010 | 624 | 2010 |
| CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts O Hansson, J Seibyl, E Stomrud, H Zetterberg, JQ Trojanowski, T Bittner, ... Alzheimer's & dementia 14 (11), 1470-1481, 2018 | 546 | 2018 |
| Current state of Alzheimer’s fluid biomarkers JL Molinuevo, S Ayton, R Batrla, MM Bednar, T Bittner, J Cummings, ... Acta neuropathologica 136, 821-853, 2018 | 491 | 2018 |
| Performance of fully automated plasma assays as screening tests for Alzheimer disease–related β-amyloid status S Palmqvist, S Janelidze, E Stomrud, H Zetterberg, J Karl, K Zink, T Bittner, ... JAMA neurology 76 (9), 1060-1069, 2019 | 359 | 2019 |
| Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1–42) in human cerebrospinal fluid T Bittner, H Zetterberg, CE Teunissen, RE Ostlund Jr, M Militello, ... Alzheimer's & dementia 12 (5), 517-526, 2016 | 301 | 2016 |
| Head-to-head comparison of 8 plasma amyloid-β 42/40 assays in Alzheimer disease S Janelidze, CE Teunissen, H Zetterberg, JA Allué, L Sarasa, ... JAMA neurology 78 (11), 1375-1382, 2021 | 221 | 2021 |
| Multiple events lead to dendritic spine loss in triple transgenic Alzheimer's disease mice T Bittner, M Fuhrmann, S Burgold, SM Ochs, N Hoffmann, G Mitteregger, ... PloS one 5 (11), e15477, 2010 | 169 | 2010 |
| Mass spectrometry–based candidate reference measurement procedure for quantification of amyloid-β in cerebrospinal fluid A Leinenbach, J Pannee, T Dülffer, A Huber, T Bittner, U Andreasson, ... Clinical chemistry 60 (7), 987-994, 2014 | 150 | 2014 |
| Rescue of progranulin deficiency associated with frontotemporal lobar degeneration by alkalizing reagents and inhibition of vacuolar ATPase A Capell, S Liebscher, K Fellerer, N Brouwers, M Willem, S Lammich, ... Journal of Neuroscience 31 (5), 1885-1894, 2011 | 150 | 2011 |
| γ-secretase inhibition reduces spine density in vivo via an amyloid precursor protein-dependent pathway T Bittner, M Fuhrmann, S Burgold, CKE Jung, C Volbracht, H Steiner, ... Journal of Neuroscience 29 (33), 10405-10409, 2009 | 138 | 2009 |
| Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: an update from the Alzheimer's Association Global Biomarkers Consortium MC Carrillo, K Blennow, H Soares, P Lewczuk, N Mattsson, P Oberoi, ... Alzheimer's & Dementia 9 (2), 137-140, 2013 | 137 | 2013 |
| CSF Aβ1–42–an excellent but complicated Alzheimer's biomarker–a route to standardisation J Kuhlmann, U Andreasson, J Pannee, M Bjerke, E Portelius, ... Clinica Chimica Acta 467, 27-33, 2017 | 127 | 2017 |
| Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in … S Salloway, LA Honigberg, W Cho, M Ward, M Friesenhahn, F Brunstein, ... Alzheimer's research & therapy 10, 1-13, 2018 | 125 | 2018 |
| Amyloid plaque formation precedes dendritic spine loss T Bittner, S Burgold, MM Dorostkar, M Fuhrmann, BM Wegenast-Braun, ... Acta neuropathologica 124, 797-807, 2012 | 121 | 2012 |
| Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer’s disease (MCI and dementia) in primary care: a review and synthesis JL Liss, S Seleri Assunção, J Cummings, A Atri, DS Geldmacher, ... Journal of internal medicine 290 (2), 310-334, 2021 | 111 | 2021 |
| In vivo multiphoton imaging reveals gradual growth of newborn amyloid plaques over weeks S Burgold, T Bittner, MM Dorostkar, D Kieser, M Fuhrmann, G Mitteregger, ... Acta neuropathologica 121, 327-335, 2011 | 100 | 2011 |
| Loss of the cellular prion protein affects the Ca2+ homeostasis in hippocampal CA1 neurons M Fuhrmann, T Bittner, G Mitteregger, N Haider, S Moosmang, ... Journal of neurochemistry 98 (6), 1876-1885, 2006 | 97 | 2006 |
| Bis (arylvinyl) pyrazines,-pyrimidines, and-pyridazines as imaging agents for tau fibrils and β-amyloid plaques in Alzheimer’s disease models A Boländer, D Kieser, C Voss, S Bauer, C Schön, S Burgold, T Bittner, ... Journal of Medicinal Chemistry 55 (21), 9170-9180, 2012 | 89 | 2012 |
| Preanalytical sample handling recommendations for Alzheimer's disease plasma biomarkers M Rózga, T Bittner, R Batrla, J Karl Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 11, 291-300, 2019 | 82 | 2019 |
| Target engagement in an alzheimer trial: Crenezumab lowers amyloid β oligomers in cerebrospinal fluid T Yang, Y Dang, B Ostaszewski, D Mengel, V Steffen, C Rabe, T Bittner, ... Annals of neurology 86 (2), 215-224, 2019 | 81 | 2019 |
Henrik ZetterbergSahlgrenskaVerified email at clinchem.gu.se
